156 related articles for article (PubMed ID: 34344457)
1. The prognostic and therapeutic implications of distinct patterns of argininosuccinate synthase 1 (ASS1) and arginase-2 (ARG2) expression by cancer cells and tumor stroma in non-small-cell lung cancer.
Giatromanolaki A; Harris AL; Koukourakis MI
Cancer Metab; 2021 Aug; 9(1):28. PubMed ID: 34344457
[TBL] [Abstract][Full Text] [Related]
2. Arginase II expressed in cancer-associated fibroblasts indicates tissue hypoxia and predicts poor outcome in patients with pancreatic cancer.
Ino Y; Yamazaki-Itoh R; Oguro S; Shimada K; Kosuge T; Zavada J; Kanai Y; Hiraoka N
PLoS One; 2013; 8(2):e55146. PubMed ID: 23424623
[TBL] [Abstract][Full Text] [Related]
3. Endogenous arginase 2 as a potential biomarker for PEGylated arginase 1 treatment in xenograft models of squamous cell lung carcinoma.
Lam SK; Yan S; Xu S; U KP; Cheng PN; Ho JC
Oncogenesis; 2019 Feb; 8(3):18. PubMed ID: 30808864
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibition is synthetically lethal with arginine deprivation in pancreatic cancers with low argininosuccinate synthetase 1 expression.
Kim SS; Xu S; Cui J; Poddar S; Le TM; Hayrapetyan H; Li L; Wu N; Moore AM; Zhou L; Yu AC; Dann AM; Elliott IA; Abt ER; Kim W; Dawson DW; Radu CG; Donahue TR
Theranostics; 2020; 10(2):829-840. PubMed ID: 31903153
[TBL] [Abstract][Full Text] [Related]
5. Argininosuccinate synthetase 1 (ASS1) is a common metabolic marker of chemosensitivity for targeted arginine- and glutamine-starvation therapy.
Long Y; Tsai WB; Wang D; Hawke DH; Savaraj N; Feun LG; Hung MC; Chen HH; Kuo MT
Cancer Lett; 2017 Mar; 388():54-63. PubMed ID: 27913198
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of Expression the Arginine Pathway Enzymes in Childhood Brain Tumours to Determine Susceptibility to Therapeutic Arginine Depletion.
Bishop E; Dimitrova M; Froggatt A; Estevez-Cebrero M; Storer LCD; Mussai F; Paine S; Grundy RG; Dandapani M
Biomed Res Int; 2022; 2022():9008685. PubMed ID: 35782058
[TBL] [Abstract][Full Text] [Related]
7. Cyclic adenosine monophosphate-induced argininosuccinate synthase 1 expression is essential during mouse decidualization.
Huang Z; Wang TS; Zhao YC; Zuo RJ; Deng WB; Chi YJ; Yang ZM
Mol Cell Endocrinol; 2014 May; 388(1-2):20-31. PubMed ID: 24556046
[TBL] [Abstract][Full Text] [Related]
8. Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progression.
Rotondo R; Mastracci L; Piazza T; Barisione G; Fabbi M; Cassanello M; Costa R; Morandi B; Astigiano S; Cesario A; Sormani MP; Ferlazzo G; Grossi F; Ratto GB; Ferrini S; Frumento G
Int J Cancer; 2008 Sep; 123(5):1108-16. PubMed ID: 18528866
[TBL] [Abstract][Full Text] [Related]
9. iNOS Expression by Tumor-Infiltrating Lymphocytes, PD-L1 and Prognosis in Non-Small-Cell Lung Cancer.
Giatromanolaki A; Tsolou A; Daridou E; Kouroupi M; Chlichlia K; Koukourakis MI
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33167430
[TBL] [Abstract][Full Text] [Related]
10. Chromatin remodeling system p300-HDAC2-Sin3A is involved in Arginine Starvation-Induced HIF-1α Degradation at the ASS1 promoter for ASS1 Derepression.
Tsai WB; Long Y; Chang JT; Savaraj N; Feun LG; Jung M; Chen HHW; Kuo MT
Sci Rep; 2017 Sep; 7(1):10814. PubMed ID: 28883660
[TBL] [Abstract][Full Text] [Related]
11. Defects in intratumoral arginine metabolism attenuate the replication and therapeutic efficacy of oncolytic myxoma virus.
Dryja P; Curtsinger HD; Bartee MY; Bartee E
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37270180
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin-induced synthetic lethality to arginine-starvation therapy by transcriptional suppression of ASS1 is regulated by DEC1, HIF-1α, and c-Myc transcription network and is independent of ASS1 promoter DNA methylation.
Long Y; Tsai WB; Chang JT; Estecio M; Wangpaichitr M; Savaraj N; Feun LG; Chen HH; Kuo MT
Oncotarget; 2016 Dec; 7(50):82658-82670. PubMed ID: 27765932
[TBL] [Abstract][Full Text] [Related]
13. The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines.
Weis-Banke SE; Hübbe ML; Holmström MO; Jørgensen MA; Bendtsen SK; Martinenaite E; Carretta M; Svane IM; Ødum N; Pedersen AW; Met Ö; Madsen DH; Andersen MH
Oncoimmunology; 2020 Jun; 9(1):1771142. PubMed ID: 32923127
[TBL] [Abstract][Full Text] [Related]
14. The arginase inhibitor Nω-hydroxy-nor-arginine (nor-NOHA) induces apoptosis in leukemic cells specifically under hypoxic conditions but CRISPR/Cas9 excludes arginase 2 (ARG2) as the functional target.
Ng KP; Manjeri A; Lee LM; Chan ZE; Tan CY; Tan QD; Majeed A; Lee KL; Chuah C; Suda T; Ong ST
PLoS One; 2018; 13(10):e0205254. PubMed ID: 30307989
[TBL] [Abstract][Full Text] [Related]
15. Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer.
Delage B; Fennell DA; Nicholson L; McNeish I; Lemoine NR; Crook T; Szlosarek PW
Int J Cancer; 2010 Jun; 126(12):2762-72. PubMed ID: 20104527
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer.
Nicholson LJ; Smith PR; Hiller L; Szlosarek PW; Kimberley C; Sehouli J; Koensgen D; Mustea A; Schmid P; Crook T
Int J Cancer; 2009 Sep; 125(6):1454-63. PubMed ID: 19533750
[TBL] [Abstract][Full Text] [Related]
17. Arginine metabolic control of airway inflammation.
Asosingh K; Lauruschkat CD; Alemagno M; Frimel M; Wanner N; Weiss K; Kessler S; Meyers DA; Bennett C; Xu W; Erzurum S
JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31996482
[TBL] [Abstract][Full Text] [Related]
18. A pan-cancer analysis of the role of argininosuccinate synthase 1 in human tumors.
Ding Q; Li R; Wang Q; Yu L; Zi F
Front Oncol; 2023; 13():1049147. PubMed ID: 38053661
[TBL] [Abstract][Full Text] [Related]
19. Argininosuccinate Synthetase-1 (ASS1) Loss in High-Grade Neuroendocrine Carcinomas of the Urinary Bladder: Implications for Targeted Therapy with ADI-PEG 20.
Gupta S; Sahu D; Bomalaski JS; Frank I; Boorjian SA; Thapa P; Cheville JC; Hansel DE
Endocr Pathol; 2018 Sep; 29(3):236-241. PubMed ID: 29453600
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic Kaposi's Sarcoma-Associated Herpesvirus Upregulates Argininosuccinate Synthase 1, a Rate-Limiting Enzyme of the Citrulline-Nitric Oxide Cycle, To Activate the STAT3 Pathway and Promote Growth Transformation.
Li T; Zhu Y; Cheng F; Lu C; Jung JU; Gao SJ
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
